These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 2657291)

  • 41. [Indications for the surgical treatment of peptic ulcer from the internal medicine viewpoint].
    Kratzsch KH; Stibenz J; Kubisch H
    Z Arztl Fortbild (Jena); 1983; 77(19):795-9. PubMed ID: 6649695
    [No Abstract]   [Full Text] [Related]  

  • 42. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapy of peptic ulcer. Antacids].
    Kurtz W
    Verh Dtsch Ges Inn Med; 1988; 94():281-4. PubMed ID: 3061196
    [No Abstract]   [Full Text] [Related]  

  • 44. Management of dyspepsia and peptic ulcer disease.
    Ryan SW
    Altern Ther Health Med; 2005; 11(5):26-9; quiz 30. PubMed ID: 16189945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Double-blind trial with Tepilta in peptic ulcer].
    Kettner W
    Z Gesamte Inn Med; 1970 Nov; 25(21):986-8. PubMed ID: 4942711
    [No Abstract]   [Full Text] [Related]  

  • 46. Antacids: the past, the present, and the future.
    Lam SK
    Baillieres Clin Gastroenterol; 1988 Jul; 2(3):641-54. PubMed ID: 3048455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Medication neutralizing gastric acidity and protecting the gastric mucosa].
    Meeroff M; Maggi LC
    Medicina (Mex); 1965 Jun; 45(966):285-9 contd. PubMed ID: 5844504
    [No Abstract]   [Full Text] [Related]  

  • 48. Advances in treatment no. 7. Gastric and duodenal ulceration and dyspepsia.
    Matts SG
    Br J Clin Pract; 1972 Oct; 26(10):467-8. PubMed ID: 5083426
    [No Abstract]   [Full Text] [Related]  

  • 49. Gastric mucosal coating and gastric emptying time of antacids. A gastrocamera study.
    Morrissey JF; Honda T; Tanaka Y; Perna G
    Arch Intern Med; 1967 May; 119(5):510-7. PubMed ID: 6024663
    [No Abstract]   [Full Text] [Related]  

  • 50. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease.
    Wilhelmsen I; Weberg R; Berstad K; Hausken T; Hundal O; Berstad A
    Hepatogastroenterology; 1994 Feb; 41(1):43-7. PubMed ID: 8175114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical treatment of peptic ulcer disease.
    Andersen BN
    Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical treating of antacids].
    Lux G; Lux E
    Fortschr Med; 1973 May; 91(14):638-40. PubMed ID: 4540765
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Medication neutralizing gastric acidity and protecting the gastric mucosa].
    Meeroff M; Maggi LC
    Medicina (Mex); 1965 May; 45(964):230-7 contd. PubMed ID: 5845110
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antacids--how do they work?].
    Fortschr Med; 1983 Oct; 101(40):1846. PubMed ID: 6642393
    [No Abstract]   [Full Text] [Related]  

  • 56. [Recent state of therapy of peptic disease].
    Pavlotzky M; Eshchar J
    Harefuah; 1985 Nov; 109(10):288-96. PubMed ID: 3912295
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antacids: what role in the treatment of ulcer disease?].
    Galmiche JP; Bruley des Varannes S; Ducrot F
    Gastroenterol Clin Biol; 1986; 10(6-7):481-5. PubMed ID: 2875914
    [No Abstract]   [Full Text] [Related]  

  • 58. Pepsins, peptic activity, and peptic inhibitors.
    Samloff IM
    J Clin Gastroenterol; 1981; 3(Suppl 2):91-4. PubMed ID: 6119339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of peptic ulcer disease and current trends in therapy.
    Desai JK; Goyal RK; Parmar NS
    Indian J Physiol Pharmacol; 1997 Jan; 41(1):3-15. PubMed ID: 10225026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
    Andersson K; Carlsson E
    Pharmacol Ther; 2005 Dec; 108(3):294-307. PubMed ID: 16000224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.